galantamine has been researched along with Depression in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, KM; Kiluk, BD; McHugh, RK; Roos, CR | 1 |
| Correll, CU; Lu, RB; Luchini, C; Solmi, M; Stubbs, B; Veronese, N; Zaninotto, L | 1 |
| Bozoglu, E; Celik, T; Doruk, H; Isik, AT | 1 |
| Osborn, GG; Saunders, AV | 1 |
| Gray, SL; McDermott, CL | 1 |
| Borson, S; Kaufer, DI; Kershaw, P; Sadik, K | 1 |
| Basun, H; Cederholm, T; Eriksdotter-Jönhagen, M; Faxén-Irving, G; Freund-Levi, Y; Garlind, A; Grut, M; Palmblad, J; Vedin, I; Wahlund, LO | 1 |
4 review(s) available for galantamine and Depression
| Article | Year |
|---|---|
Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions.
Topics: Adult; Bipolar Disorder; Case-Control Studies; Cholinesterase Inhibitors; Clinical Trials as Topic; Depression; Depressive Disorder; Donepezil; Evidence-Based Medicine; Excitatory Amino Acid Antagonists; Female; Galantamine; Humans; Indans; Male; Memantine; Middle Aged; Piperidines; Psychotic Disorders; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Current treatments for patients with Alzheimer disease.
Topics: Aggression; Alzheimer Disease; Behavior Therapy; Cholinesterase Inhibitors; Depression; Excitatory Amino Acid Antagonists; Galantamine; Health Status; Humans; Memantine; Neuroprotective Agents; Parasympathomimetics; Phenylcarbamates; Psychomotor Agitation; Psychotherapy; Psychotic Disorders; Rivastigmine; Time Factors; United States; United States Food and Drug Administration | 2010 |
Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression.
Topics: Antidepressive Agents; Cholinesterase Inhibitors; Cognition Disorders; Depression; Donepezil; Drug Therapy, Combination; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine | 2012 |
Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine.
Topics: Aged; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Cost of Illness; Depression; Employment; Galantamine; Humans; Sleep Wake Disorders | 2005 |
3 trial(s) available for galantamine and Depression
| Article | Year |
|---|---|
Evaluating a longitudinal mediation model of perceived stress, depressive symptoms, and substance use treatment outcomes.
Topics: Adult; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Depression; Female; Galantamine; Humans; Male; Methadone; Middle Aged; Models, Psychological; Opiate Substitution Treatment; Opioid-Related Disorders; Prospective Studies; Stress, Psychological; Treatment Outcome | 2020 |
Trospium and cognition in patients with late onset Alzheimer disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Benzilates; Cholinesterase Inhibitors; Cognition; Depression; Drug Interactions; Drug Therapy, Combination; Female; Galantamine; Geriatric Assessment; Humans; Male; Mental Health; Muscarinic Antagonists; Nocturia; Nortropanes; Patient Satisfaction; Urinary Incontinence | 2009 |
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Analysis of Variance; Apolipoproteins E; Cholinesterase Inhibitors; Depression; Dietary Supplements; Donepezil; Double-Blind Method; Fatty Acids, Omega-3; Female; Galantamine; Genotype; Humans; Indans; Male; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine; Statistics, Nonparametric; Treatment Outcome | 2008 |